Euro zone bond yields were little changed on Tuesday, with the focus of global markets on the Bank of Japan, which ended eight years of negative interest rates. ** Germany's 10-year bond yield, the benchmark for the euro zone, was last up less than 1 basis point (bp) at 2.462%. ** Germany's 2-year bond yield was also up less than 1 bp at 2.923%.
AstraZeneca said on Tuesday it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc for about $2 billion in cash to boost its oncology portfolio. The drugmaker will pay $21 per Fusion share, a premium of more than 97% to the U.S.-listed company's closing price on Monday. AstraZeneca will also pay a non-transferable contingent value right of $3 per share, taking the combined transaction value to about $2.4 billion.
Thyssenkrupp on Tuesday said it has entered a due diligence phase on the potential partial sale of its marine unit with investment firm Carlyle . "With the active involvement of Carlyle, we are now taking the necessary next step and starting the phase of an open-ended assessment of the relevant business activities," Thyssenkrupp's Executive Board member Volkmar Dinstuhl said in a statement. The sale to Carlyle is one of the several options that the firm is currently considering, he added.